A state-wide system of medication management services provided by
specially trained hospital and community pharmacists serving high-risk individuals (≥65 years old) from hospitalization through transition to home and for up to 1 year after discharge.
Estimated annual cost of
admissions (≥65 years old)
associated with intervention: $6,626,913
Actual annual cost of
Estimated ROI in pharmacist
Reductions in 30-day Readmission, Mortality, and Costs with Pharmacist Follow-up
Patients discharged from any of 4 hospitals with chronic obstructive
pulmonary disease, pneumonia, heart failure, acute myocardial infarction, or diabetes within Pennsylvania. Patients in the intervention group received consultative services from inpatient pharmacists before discharge and inpatient-to-community pharmacist communication of hospitalization information facilitated with the use of a secure messaging system. After discharge, patients received up to 5 in-person or telephonic medication management consultations with their community
Observed lower 30-day readmission rate, 30-day all-cause mortality, and composite 30-day end point (readmission, ED visit, or death) in intervention group
Estimated average ROI of 8.1 per discharge
Economic Value of Pharmacist-Led Medication Reconciliation for Reducing Medication Errors After Hospital Discharge
A pharmacist-led medication reconciliation service at a hospital can reduce medication discrepancies by around 52%, which would lead to an increased cost savings by preventing adverse drug events (ADEs).
The cost of preventable ADEs could be reduced to $206 per patient
Impact of a pharmacy-based transitional care program on hospital readmissions.
This study evaluates the impact of a community pharmacy-based postdischarge TOC program on hospital readmissions for members of a US managed Medicaid health plan . Over 1100 high-risk patients were referred to Synergy Pharmacy Solutions from the Kern Health Systems managed Medicaid plan between April 2013 and March 2015.
The postdischarge intervention reduced the risk of readmission
Within 30 days: 28%
Reduced number of
readmissions by 6 per
Within 180 days: 31.9%
Reduced number of
readmissions by 19 per